STAAR SURGICAL COMPANY
10-Q/A, EX-27, 2000-09-29
OPHTHALMIC GOODS
Previous: STAAR SURGICAL COMPANY, 10-Q/A, 2000-09-29
Next: CONSECO INC, 8-K, 2000-09-29



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-29-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       4,262,845
<SECURITIES>                                         0
<RECEIVABLES>                                8,675,947
<ALLOWANCES>                                   650,607
<INVENTORY>                                 19,279,349
<CURRENT-ASSETS>                            39,842,326
<PP&E>                                      28,308,136
<DEPRECIATION>                              15,893,457
<TOTAL-ASSETS>                              76,979,044
<CURRENT-LIABILITIES>                       37,603,378
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       149,939
<OTHER-SE>                                  35,914,182
<TOTAL-LIABILITY-AND-EQUITY>                76,979,044
<SALES>                                     26,870,185
<TOTAL-REVENUES>                            26,986,256
<CGS>                                       15,610,443
<TOTAL-COSTS>                               31,797,967
<OTHER-EXPENSES>                             4,879,058
<LOSS-PROVISION>                                39,614
<INTEREST-EXPENSE>                             821,468
<INCOME-PRETAX>                           (24,448,819)
<INCOME-TAX>                               (6,251,318)
<INCOME-CONTINUING>                       (18,250,514)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (18,250,514)
<EPS-BASIC>                                     (1.23)
<EPS-DILUTED>                                   (1.23)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission